- LFMD Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
CORRESP Filing
LifeMD (LFMD) CORRESPCorrespondence with SEC
Filed: 17 Jun 21, 12:00am
June 17, 2021
Via EDGAR
Securities and Exchange Commission
100 F Street N.E.
Washington, D.C. 20549-7010
Re: | LifeMD, Inc. |
Amendment No. 1 to Registration Statement on Form S-3/A | |
Filed June 17, 2021 | |
File No. 333-256911 |
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, LifeMD, Inc. (the “Company”) hereby respectfully requests that the Securities and Exchange Commission (the “Commission”) accelerate the effective date of the above-referenced Registration Statement to June 21, 2021 at 4:00 p.m. (Eastern) or as soon thereafter as is practicable.
If you have any questions concerning this request, or if you require any additional information, please feel free to contact Anthony Marsico of Dorsey & Whitney LLP, attorney for the Registrant, at (212) 953-7201.
The Company requests that the Commission notify Mr. Marsico of effectiveness by telephone call and that such effectiveness also be confirmed in writing.
LIFEMD, INC. | ||
By: | /s/ Justin Schreiber | |
Name: | Justin Schreiber | |
Title: | Chief Executive Officer |